JAGX
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Nov 28, 2:24 PM EST
LGVN
Price
$1.95
Change
+$0.07 (+3.72%)
Updated
Nov 28, 2:20 PM EST
101 days until earnings call
Ad is loading...

JAGX vs LGVN ᐉ Comparison: Which is Better to Invest?

Header iconJAGX vs LGVN Comparison
Open Charts JAGX vs LGVNBanner chart's image
Jaguar Health
Price$0.35
Change-$0.00 (-0.00%)
Volume$131
CapitalizationN/A
Longeveron
Price$1.95
Change+$0.07 (+3.72%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
JAGX vs LGVN Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
JAGX vs. LGVN commentary
Nov 28, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Sell and LGVN is a Hold.

COMPARISON
Comparison
Nov 28, 2023
Stock price -- (JAGX: $0.35 vs. LGVN: $1.88)
Brand notoriety: JAGX and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 42% vs. LGVN: 10%
Market capitalization -- JAGX: $18.97M vs. LGVN: $46.31M
JAGX [@Biotechnology] is valued at $18.97M. LGVN’s [@Biotechnology] market capitalization is $46.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $467.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 0 FA rating(s) are green whileLGVN’s FA Score has 0 green FA rating(s).

  • JAGX’s FA Score: 0 green, 5 red.
  • LGVN’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 5 TA indicator(s) are bullish while LGVN’s TA Score has 5 bullish TA indicator(s).

  • JAGX’s TA Score: 5 bullish, 4 bearish.
  • LGVN’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than JAGX.

Price Growth

JAGX (@Biotechnology) experienced а -24.31% price change this week, while LGVN (@Biotechnology) price change was -2.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.61%. For the same industry, the average monthly price growth was +34.23%, and the average quarterly price growth was +7.29%.

Reported Earning Dates

JAGX is expected to report earnings on May 19, 2023.

LGVN is expected to report earnings on Mar 08, 2024.

Industries' Descriptions

@Biotechnology (+5.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for JAGX with price predictions.
OPEN
A.I.dvisor published
a Summary for LGVN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LGVN($46.3M) has a higher market cap than JAGX($19M). LGVN YTD gains are higher at: -41.615 vs. JAGX (-94.634). LGVN has higher annual earnings (EBITDA): -20.68M vs. JAGX (-29.66M). LGVN has more cash in the bank: 3.93M vs. JAGX (3.23M). LGVN has less debt than JAGX: LGVN (2.19M) vs JAGX (35.5M). JAGX has higher revenues than LGVN: JAGX (10.7M) vs LGVN (767K).
JAGXLGVNJAGX / LGVN
Capitalization19M46.3M41%
EBITDA-29.66M-20.68M143%
Gain YTD-94.634-41.615227%
P/E RatioN/AN/A-
Revenue10.7M767K1,395%
Total Cash3.23M3.93M82%
Total Debt35.5M2.19M1,625%
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGXLGVN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILV5.930.20
+3.49%
SilverCrest Metals
NEON1.16N/A
N/A
Neonode
AVB171.88-1.49
-0.86%
AvalonBay Communities
COFS24.58-0.59
-2.34%
ChoiceOne Financial Services
MQ6.14-0.21
-3.31%
Marqeta

JAGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAGX has been loosely correlated with IBRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if JAGX jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
-6.42%
IBRX - JAGX
37%
Loosely correlated
+2.43%
HEPA - JAGX
29%
Poorly correlated
-5.10%
LGVN - JAGX
28%
Poorly correlated
-3.59%
VXRT - JAGX
28%
Poorly correlated
+2.22%
SRNEQ - JAGX
27%
Poorly correlated
-11.54%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with SRPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-3.59%
SRPT - LGVN
34%
Loosely correlated
-0.35%
ENTA - LGVN
34%
Loosely correlated
-3.62%
FATE - LGVN
33%
Loosely correlated
-3.39%
SRNEQ - LGVN
33%
Loosely correlated
-11.54%
AXON - LGVN
30%
Poorly correlated
-0.11%
More